Letter from Jean-Christophe Pointeau
China President, Pfizer Global Biopharma Business Group
Inflammation & Immunology
In 2022, we reached an estimated 1.4 billion patients with our medicines and vaccines. That’s more than one out of every six people on Earth. Never before has Pfizer’s patient impact been so wide-reaching.